Snowball logo
logo
PRGO_logo

Perrigo Company plc

$12.83+$0.14ย  (1.1%)
Estimate
EPS
-11.61
Beta
0.536
Growth
Revenue, YoY
-3.17%
Net income, YoY
986.9%
FCF, YoY
118.69%
Forecast
P/E (FWD)
5.4
EPS (FWD)
2.366
Dividends
Dividend yield
9.04%
Annual payout
$1.16
Next ex. div date
August 28, 26
Div.growth, 5y
5.21%
Dividend growth streak
12 y
Div.rating
About the company
Ticker
PRGO
ISIN
IE00BGH1M568
Country
Ireland
Sector (GICS)
Healthcare
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Frequently asked questions

What sector does Perrigo Company plc (PRGO) operate in?

Perrigo Company plc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Perrigo Company plc (PRGO) current stock price?

As of the latest data, Perrigo Company plc stock price is $12.83, with a previous close of $12.69. Perrigo Company plc gained $0.14 in the last trading session, representing a 1.1% increase.

What is Perrigo Company plc (PRGO) current market capitalization?

Perrigo Company plc market cap is approximately 1.78 billion.

What is Perrigo Company plc (PRGO) Earnings Per Share (EPS)?

The trailing EPS is -$11.61, and the forward EPS is $2.37.

What is Perrigo Company plc (PRGO) EBITDA?

Perrigo Company plc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 143.80 million.

Does Perrigo Company plc (PRGO) pay dividends?

Yes. Perrigo Company plc pays quarterly dividends with an annualized yield of 9.04% and an estimated annual payout of $1.16 per share.

When is the next ex-dividend date for Perrigo Company plc (PRGO)?

The next ex-dividend date is scheduled for August 28, 2026.

How did Perrigo Company plc (PRGO) perform in its most recent earnings report?

In the last report (June 30, 2026), Perrigo Company plc posted an EPS surprise of 61.29% and a revenue surprise of 1.25%.

What is Perrigo Company plc (PRGO) beta (volatility) score?

Perrigo Company plc has a beta of 0.536, indicating lower volatility than the overall market.